Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Treatment of chronic cough: P2X3 receptor antagonists and beyond
Dominic L. Sykes, Mengru Zhang, Alyn H. Morice
Pharmacology & Therapeutics (2022) Vol. 237, pp. 108166-108166
Closed Access | Times Cited: 15

Showing 15 citing articles:

Chronic cough—the limitation and advances in assessment techniques
Mengru Zhang, Dominic L. Sykes, Kayleigh Brindle, et al.
Journal of Thoracic Disease (2022) Vol. 14, Iss. 12, pp. 5097-5119
Open Access | Times Cited: 24
Call for Papers – Purinergic Signaling: Medicinal Chemistry, Biology, Pharmacology, and Translation into Diagnostic and Therapeutic Drugs
Christa E. Müller, Annette Nicke, Christian Lohr, et al.
ACS Pharmacology & Translational Science (2025)
Closed Access
Antitussive efficacy of the current treatment protocol for refractory chronic cough: our real-world experience in a retrospective cohort study
Mengru Zhang, Alyn H. Morice, Fengli Si, et al.
Therapeutic Advances in Respiratory Disease (2023) Vol. 17
Open Access | Times Cited: 8
Unravelling vagal hypersensitivity in chronic cough: A distinct disease
Mengru Zhang, Alyn H. Morice
The Journal of Physiology (2023) Vol. 602, Iss. 22, pp. 6039-6046
Closed Access | Times Cited: 7
Dilation of ion selectivity filters in cation channels
Kate Huffer, Xiao-Feng Tan, Ana I. Fernández-Mariño, et al.
Trends in Biochemical Sciences (2024) Vol. 49, Iss. 5, pp. 417-430
Closed Access | Times Cited: 2
P2X3 and P2X2/3 Receptors Inhibition Produces a Consistent Analgesic Efficacy: A Systematic Review and Meta-Analysis of Preclinical Studies
Miguel Á. Huerta, Daniel Marcos-Frutos, Javier de la Nava, et al.
European Journal of Pharmacology (2024) Vol. 984, pp. 177052-177052
Open Access | Times Cited: 2
Smart Devices Are Poised to Revolutionize the Usefulness of Respiratory Sounds
Steve S. Kraman, Hans Pasterkamp, George R. Wodicka
CHEST Journal (2023) Vol. 163, Iss. 6, pp. 1519-1528
Closed Access | Times Cited: 4
Safety and Pharmacokinetics of HRS-2261, a P2X3 Receptor Antagonist, in Healthy Subjects: A Randomized, Double-Blind, Placebo-Controlled Phase 1 Study
Yuru Fan, Xuan Zhang, Qin Zhang, et al.
Clinical Pharmacokinetics (2024) Vol. 63, Iss. 3, pp. 293-302
Closed Access | Times Cited: 1
Discovery of Triazolopyrimidine Derivatives as Selective P2X3 Receptor Antagonists Binding to an Unprecedented Allosteric Site as Evidenced by Cryo-Electron Microscopy
Garam Kim, Subin Kim, Yeo Ok Kim, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 16, pp. 14443-14465
Closed Access | Times Cited: 1
Drugs Targeting Cough Receptors: New Therapeutic Options in Refractory or Unexplained Chronic Cough
Laurent Guilleminault, Stanislas Grassin‐Delyle, Stuart B. Mazzone
Drugs (2024) Vol. 84, Iss. 7, pp. 763-777
Closed Access
Cerebellar ataxia, neuropathy and vestibular areflexia syndrome: a neurogenic cough prototype
Laurent Guilleminault, Stuart B. Mazzone, Pauline Chazelas, et al.
ERJ Open Research (2024) Vol. 10, Iss. 4, pp. 00024-2024
Open Access
Chronic Bronchitis in Children and Adults: Definitions, Pathophysiology, Prevalence, Risk Factors, and Consequences
Jingwen Zhang, Danielle Wurzel, Jennifer L. Perret, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 8, pp. 2413-2413
Open Access
The discovery and development of gefapixant as a novel antitussive therapy
Maria Gabriella Matera, Paola Rogliani, Clive P. Page, et al.
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 10, pp. 1159-1172
Closed Access
Druggable site near the upper vestibule determines the high affinity and P2X3 homotrimer selectivity of sivopixant/S‐600918 and its analogue DDTPA
Dongping Wang, Meng Zhang, Ming Li, et al.
British Journal of Pharmacology (2023) Vol. 181, Iss. 8, pp. 1203-1220
Closed Access | Times Cited: 1
Novel P2X3 Inhibitors for Treating Neurogenic Disorders
Ram W. Sabnis
ACS Medicinal Chemistry Letters (2023) Vol. 14, Iss. 9, pp. 1146-1147
Closed Access
Page 1

Scroll to top